EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
Abstract Small intestinal neuroendocrine tumors (SI-NETs) are slow-growing tumors that seem genetically quite stable without highly recurrent mutations, but are epigenetically dysregulated. In contrast to the undetectable expression of the enhancer of zeste homolog 2 (EZH2) histone methyltransferase...
Guardado en:
Autores principales: | Elham Barazeghi, Per Hellman, Olov Norlén, Gunnar Westin, Peter Stålberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d351b9e2cae3458c9b1d12c37c08e7b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors
por: Anna Bryan Stensbøl, et al.
Publicado: (2021) -
Early life exposures associated with risk of small intestinal neuroendocrine tumors.
por: James VanDerslice, et al.
Publicado: (2020) -
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
por: Dirk Walter, et al.
Publicado: (2018) -
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
por: Erik Elias, et al.
Publicado: (2021) -
Identification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumors.
por: Spyros Darmanis, et al.
Publicado: (2013)